Orally Disintegrating Tablet Market by Key Regions, Production, Consumption, Revenue, Share and Growth 2019 - 2029

Orally Disintegrating Tablet Market 2022

Orally Disintegrating Tablet Market is expected to grow on a decent note, i.e. reach US$ 12 Bn in 2018 at a CAGR of 10% between 2019 - 2029. VR-based healthcare solution providers are creating ripples and are expected to continue with the same even in the forecast period. The services include critical procedure simulations, medical training, stroke rehabilitation, non-motor and motor rehabilitation, pain relief, autism care, anxiety reduction, and even battling depression. This would be the case with the healthcare vertical shortly.

Click Here to Get Free Sample Copy of This Report@https://www.persistencemarketresearch.com/samples/14572

Improvements in drug delivery mechanism offering quicker onset of action with superior bioavailability per dose have transformed characteristics of orally administered drugs with the development of orally disintegrating tablets (ODTs). The global orally disintegrating tablets market was valued at nearly US$ 12 Bn in 2018 and will exhibit a solid CAGR during the forecast period (2019 - 2029).

There has been growing preference among consumers and patients for orally disintegrating tablets attributed to increasing applications in treatment of diseases related to central nervous system (CNS), gastrointestinal (GI), cardiovascular disorders, and allergy. Bayer's acquisition of Merck's consumer care unit was aimed at gaining shares in ODTs. Claritin, an ODT received through this acquisition, was the largest revenue generating drug for allergy in the U.S. that year.

Request For Customization@https://www.persistencemarketresearch.com/request-customization/14572

Key Takeaways - Orally Disintegrating Tablets Market Study

CNS diseases remain the primary area of application for orally disintegrating tablets. Researchers and healthcare providers are increasingly focusing on medical conditions such as encephalitis, autism, Alzheimer's disease, schizophrenia, depressive disorders and others to increase the application of orally disintegrating tablets.

Formulation process of orally disintegrating tablets is usually patented by manufacturers depending on the technology employed during the production such as lyophilization, freeze drying, and floss formation. Many technologies such as ZYDIS®, LYOC® and QUICKSOLV® are dependent on freeze drying method.

Easy disintegration of orally disintegrating tablets in saliva within a few seconds and accuracy of dose as compared to liquid forms and chewable tablet are expected to increase the adoption of ODTs in diseases such as ulcers of throat.

Attributed to consumers facing swallowing problems, bitter taste of drugs, and patient incompliance, manufacturers are focusing to improve drug formulations. This would help them gain an edge in terms of innovation, further favoring the growth of orally disintegrating tablets market.

Click Here to Get this Report@ https://www.persistencemarketresearch.com/checkout/14572

Key Manufacturers Exploring New Business Models

The global orally disintegrating tablets market is fragmented with low entry barriers inspiring generic manufacturers to tap market opportunities in the form of ANDA, arising from the expiry of patent regime of approved drugs. For instance, Mylan N.V. launched Lansoprazole DR ODT, a generic version of Takeda's Prevacid® SoluTab DR ODT. The entry of The Himalaya Drug Company LTD. and Banyan Botanicals with new herbal ODT product offerings in next few years is expected to increase product lines and extension in ODTs market.

Read Also-

Cell Culture Media Market - https://www.persistencemarketresearch.com/market-research/cell-culture-media-market.asp

Sleep Aids Market - https://www.persistencemarketresearch.com/market-research/sleep-aids-market.asp

Media Contact:

Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About PersistenceMarketResearch:

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

This release was published on openPR.